Avecho Biotechnology Ltd (Avecho) is based in Melbourne, Australia, and is listed on the Australian Securities Exchange - ASX:AVE. Avecho develops and commercialises innovative human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM®). TPM® is derived from Vitamin E using proprietary and patented processes, and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Avecho is actively developing a number of products with its unique TPM® technology, independently and with strategic partners. For more information, please visit avecho.com.au.